【ChiCTR2000034163】Instructions of daily care in overweight and obese knee osteoarthritis participants
ChiCTR2000034163
尚未开始
/
/
/
2020-06-26
/
/
膝骨关节炎
Instructions of daily care in overweight and obese knee osteoarthritis participants
Feasibility and acceptability of instructions of daily care in overweight and obese knee osteoarthritis participants
54000
To assess the effectiveness and acceptability of instructions of daily care (IDC) on pain, mobility and body mass index among knee osteoarthritis (OA) participants who are overweight or obese.
随机平行对照
其它
Randomization will be done by a computer generated number. After randomization each group will be called separately for their interventions.
Open Label
None
/
20
/
2020-04-15
2020-08-14
/
Overweight or obese knee osteoarthritis participants with grade 2 or 3 (based on Kellgren and Lawrence radiographic scale) Both males and females, Age between 45-60 years, Residing in the urban community of Lahore.；
请登录查看Rheumatoid arthritis; Orthopaedic problem; Spinal deformities or Any previous injections of the knee.；
请登录查看Medical Superintendent, Dr Farid Ahmad Chaudhary
54000
Medical Superintendent, Dr Farid Ahmad Chaudhary的其他临床试验
- The effects of strength training in knee osteoarthritis patients
- Instructions of daily care in overweight and obese knee osteoarthritis participants
- Effectiveness of lower limb rehabilitation protocol using mobile health (LLRP-mHealth) on quality of life, functional strength and functional capacity among knee osteoarthritis patients who are overweight and obese.
巴基斯坦拉合尔木尔坦路木尔坦崇基旁遮普雇员社会保障机构心脏病学研究生院的其他临床试验
- The effects of strength training in knee osteoarthritis patients
- Instructions of daily care in overweight and obese knee osteoarthritis participants
- Effectiveness of lower limb rehabilitation protocol using mobile health (LLRP-mHealth) on quality of life, functional strength and functional capacity among knee osteoarthritis patients who are overweight and obese.
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10